KINDEVA DRUG DELIVERY LP

Overview

KINDEVA DRUG DELIVERY LP is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering CLIMARA PRO(R) ESTRADIOL/LEVONORGESTREL TRANSDERMAL DELIVERY SYSTEM; COATING AND DRYING PROCESS FOR THE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM (sMTS) FINISHED DRUG PRODUCT; ESTRADIOL TRANSDERMAL DRUG DELIVERY SYSTEM.

API / Drug Master Files

KINDEVA DRUG DELIVERY LP holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• COATING AND DRYING PROCESS FOR THE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM (sMTS) FINISHED DRUG PRODUCTActive2011-03-10
• CLIMARA PRO(R) ESTRADIOL/LEVONORGESTREL TRANSDERMAL DELIVERY SYSTEMActive2000-06-16
• ESTRADIOL TRANSDERMAL DRUG DELIVERY SYSTEMActive1992-08-31

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to KINDEVA DRUG DELIVERY LP in our records. PharmaTek screens the full directory against live FDA enforcement data.